0 items USD 0.00Search
Your search for "globaldata pharmapoint schizophrenia us drug forecast market analysis 2022" gave back 48735 results.
Neurorehabilitation systems are innovative technical solutions for monitoring and reviewing neural activity.Patients recovering from nerve contusions...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Paliperidone, sold under the trade name Invega among others, is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Amisulpride (CAS 71675-85-9), C17H27N3O4S, the formula weight is 369.48, and its form is white solid. The “Amisulpride Industry Forecast” looks at...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Flupentixol has a strong antipsychotic effect, which is 4 ~ 8 times stronger than cloprothiazide, and the sedative effect is weaker.At the same time...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Amisulpride market size was valued at US$ million in 2023. With growing demand in downstream market, the Amisulpride is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Flupentixol has a strong antipsychotic effect, which is 4 ~ 8 times stronger than cloprothiazide, and the sedative effect is weaker.At the same time...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Lurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Long-Acting Injectable (LAI) Antipsychotic market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is...
Catalog:
LPI
May 2023
Price: USD 3,660.00
Clozapine is indicated in the management of symptoms of treatment-resistant schizophrenia. Publisher' newest research report, the “Clozapine...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Long-Acting Injectable (LAI) Antipsychotic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during...
Catalog:
GIR
May 2023
Price: USD 4,480.00
Digital Therapeutics for Psychiatric Illnesses are software program-driven, evidence-based interventions for the treatment, management or prevention...
Catalog:
GIR
February 2023
Price: USD 4,480.00
Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
